KD Logo

Regeneron Pharmaceuticals, Inc. (REGN) rating initates by Bernstein

Regeneron Pharmaceuticals, Inc.’s recent filing unveils that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on Apr 01 ’24. In the deal valued at $964.73 per share,250 shares were sold. As a result of this transaction, McCourt Marion now holds 13,181 shares worth roughly $11.82 million.

Then, RYAN ARTHUR F sold 100 shares, generating $96,253 in total proceeds. Upon selling the shares at $962.53, the Director now owns 18,182 shares.

Before that, MURPHY ANDREW J sold 5,783 shares. Regeneron Pharmaceuticals, Inc. shares valued at $5,531,290 were divested by the EVP Research at a price of $956.47 per share. As a result of the transaction, MURPHY ANDREW J now holds 48,306 shares, worth roughly $43.32 million.

Bernstein initiated its Regeneron Pharmaceuticals, Inc. [REGN] rating to an Outperform in a research note published on March 12, 2024; the price target was $1125. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid January from “a Sector perform” to “an Outperform”. Deutsche Bank began covering REGN with “Hold” recommendation on November 09, 2023. Raymond James revised its rating on November 03, 2023. It rated REGN as “an Outperform” which previously was an “a Mkt perform”.

Price Performance Review of REGN

On Friday, Regeneron Pharmaceuticals, Inc. [NASDAQ:REGN] saw its stock jump 0.32% to $896.82. Over the last five days, the stock has lost -0.87%. Regeneron Pharmaceuticals, Inc. shares have risen nearly 2.11% since the year began. Nevertheless, the stocks have risen 10.87% over the past one year. While a 52-week high of $998.33 was reached on 02/28/24, a 52-week low of $684.80 was recorded on 01/02/24. SMA at 50 days reached $952.79, while 200 days put it at $859.22. A total of 0.51 million shares were traded, compared to the trading of 0.45 million shares in the previous session.

Levels Of Support And Resistance For REGN Stock

The 24-hour chart illustrates a support level at 885.28, which if violated will result in even more drops to 873.73. On the upside, there is a resistance level at 914.55. A further resistance level may holdings at 932.27. The Relative Strength Index (RSI) on the 14-day chart is 30.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -25.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.10%. Stochastics %K at 8.92% indicates the stock is a buying.

Most Popular

[the_ad id="945"]